Individuals Discontinuing Weight-Loss Injections Put On Weight Far More Rapidly Compared to Dieters

New research suggests that individuals who discontinue blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover shed pounds at a significantly accelerated pace than those who stop conventional lifestyle regimens.

Findings released in a prominent medical journal points out that while overweight people often shed substantial amounts of their body weight while undergoing treatment, the mass comes back at an estimated rate of 0.8 kg per month once they quit.

"People using these medications need to be cognizant of the risk of rapid weight regain when the treatment concludes," cautioned researcher Dr. Susan Jebb.

That rate of regain means a return to original mass within about one and a half years.

Comparing Treatments

The study, which examined dozens of studies involving thousands of participants, contrasted the effects of GLP-1 agonists with older methods.

Scientists note that individuals who shed pounds through lifestyle changes alone generally have a slower creep back—around 0.1 kg a month—once they finish.

Explaining the Rapid Regain

Doctors propose the mechanism of the drugs explains the accelerated weight return.

The injections copy a natural hormone called glucagon-like peptide-1, which controls hunger.

"Sustained high doses of the hormone levels several times higher than the body's typical production may cause the body to produce less of its own natural hormone, and could reduce sensitivity to its effects," said Dr. Adam Collins, a dietetics researcher.

"Withdrawal of this GLP-1 'fix' means hunger is uncontrolled, making overeating far more likely."

An Ongoing Issue?

Health authorities recommend the injections for people with obesity-related medical conditions, alongside prescribed lifestyle changes.

Professionals say that, given the likelihood of weight regain, the therapy should be considered long-term.

This opinion is echoed by pharmaceutical companies, who say that the findings "underscore the long-term character of obesity," comparing it to managing diseases like diabetes.

User Experiences

Users who have come off the medication report a powerful return of hunger.

"I experienced a switch that goes on and I was suddenly ravenous," said an individual.

This challenge is exacerbated if patients have not developed sustainable dietary or behavioural modifications during therapy.

Widespread Interest

Figures show that millions of people in the UK have used these injections in the past year, with interest remaining high.

• Use is greater among females compared to men.
• The middle-aged age group shows the greatest usage rates.
• A large proportion obtain the medications through private healthcare rather than public health services.

In conclusion, experts caution that while these medications are effective tools for weight loss, they are not a permanent solution and maintained weight loss relies on integrated behavioural management.